These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18607200)

  • 21. Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis.
    Swanton JK; Fernando KT; Dalton CM; Miszkiel KA; Altmann DR; Plant GT; Thompson AJ; Miller DH
    Mult Scler; 2010 Feb; 16(2):156-65. PubMed ID: 20086028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study.
    Duan Y; Liu Y; Liang P; Jia X; Yu C; Qin W; Sun H; Liao Z; Ye J; Li K
    Eur J Radiol; 2012 Feb; 81(2):e110-4. PubMed ID: 21316170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?
    Korteweg T; Rovaris M; Neacsu V; Filippi M; Comi G; Uitdehaag BM; Knol DL; Polman CH; Barkhof F; Vrenken H;
    Mult Scler; 2009 Apr; 15(4):465-71. PubMed ID: 19091881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
    Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
    Camicioli R; Sabino J; Gee M; Bouchard T; Fisher N; Hanstock C; Emery D; Martin WR
    Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease.
    Peters N; Holtmannspötter M; Opherk C; Gschwendtner A; Herzog J; Sämann P; Dichgans M
    Neurology; 2006 May; 66(10):1517-22. PubMed ID: 16717211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction.
    Rovaris M; Comi G; Filippi M
    J Neurol Sci; 2006 Jun; 245(1-2):111-6. PubMed ID: 16626748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.
    Amato MP; Zipoli V; Portaccio E
    J Neurol Sci; 2006 Jun; 245(1-2):41-6. PubMed ID: 16643953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spinal cord imaging in multiple sclerosis.
    Tench CR; Morgan PS; Jaspan T; Auer DP; Constantinescu CS
    J Neuroimaging; 2005; 15(4 Suppl):94S-102S. PubMed ID: 16385022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The measurement and clinical relevance of brain atrophy in multiple sclerosis.
    Bermel RA; Bakshi R
    Lancet Neurol; 2006 Feb; 5(2):158-70. PubMed ID: 16426992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroimaging insights into network-based neurodegeneration.
    Greicius MD; Kimmel DL
    Curr Opin Neurol; 2012 Dec; 25(6):727-34. PubMed ID: 23108250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced magnetic resonance imaging of neurodegenerative diseases.
    Agosta F; Galantucci S; Filippi M
    Neurol Sci; 2017 Jan; 38(1):41-51. PubMed ID: 27848119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the blood-brain barrier status closely correlate with the rate of disease progression in patients with multiple system atrophy: a longitudinal study.
    Lee JE; Song SK; Hong JY; Sunwoo MK; Park HJ; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2013 Apr; 19(4):450-2. PubMed ID: 23298807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging plus X: multimodal models of neurodegenerative disease.
    Oxtoby NP; Alexander DC;
    Curr Opin Neurol; 2017 Aug; 30(4):371-379. PubMed ID: 28520598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [MRI in dementia-type diseases].
    Bodea SV; Mühl-Benninghaus R
    Radiologe; 2015 May; 55(5):397-402. PubMed ID: 25944274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI findings in benign multiple sclerosis are variable.
    Pittock SJ; Noseworthy JH; Rodriguez M
    J Neurol; 2007 Apr; 254(4):539-41. PubMed ID: 16944348
    [No Abstract]   [Full Text] [Related]  

  • 37. Presymptomatic and longitudinal neuroimaging in neurodegeneration--from snapshots to motion picture: a systematic review.
    Schuster C; Elamin M; Hardiman O; Bede P
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1089-96. PubMed ID: 25632156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal fMRI studies: Exploring brain plasticity and repair in MS.
    Enzinger C; Pinter D; Rocca MA; De Luca J; Sastre-Garriga J; Audoin B; Filippi M
    Mult Scler; 2016 Mar; 22(3):269-78. PubMed ID: 26683590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A population-based study on the influence of brain atrophy on 20-year survival after age 85.
    Olesen PJ; Guo X; Gustafson D; Börjesson-Hanson A; Sacuíu S; Eckerström C; Bigler ED; Skoog I
    Neurology; 2011 Mar; 76(10):879-86. PubMed ID: 21383324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between blood pressure levels over time and brain atrophy in the elderly.
    Heijer Td; Skoog I; Oudkerk M; de Leeuw FE; de Groot JC; Hofman A; Breteler MM
    Neurobiol Aging; 2003; 24(2):307-13. PubMed ID: 12498964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.